Columbia Sportswear Company (COLM) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
24 Apr, 2026Voting matters and shareholder proposals
Election of ten directors, including Timothy P. Boyle, Kevin Mansell, and others, is up for vote at the annual meeting.
Ratification of Deloitte & Touche LLP as the independent registered public accounting firm for 2026 is proposed.
Advisory, non-binding vote on executive compensation is included.
Approval of the Amended and Restated 2020 Stock Incentive Plan is on the agenda.
Shareholder proposal regarding proxy access is presented, with the board recommending a vote against it.
Board of directors and corporate governance
Ten nominees are listed for election to the board, reflecting a mix of current and potentially new directors.
Audit committee and external auditor matters
Proposal to ratify Deloitte & Touche LLP as the independent auditor for the 2026 fiscal year.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Columbia Sportswear Company
- Q2 2026 sales rose 2% and margins surged on a $78M tariff refund, driving higher EPS.COLM
Q2 2026 - Board elections, key proposals, and 2025 results highlighted modest growth and strategic shifts.COLM
AGM 2026 - Q1 2026 sales held steady at $779M as innovation and digital growth drive long-term strategy.COLM
Investor presentation - Flat Q1 sales, improved FY2026 outlook, and strong international growth offset U.S. softness.COLM
Q1 2026 - 2025 delivered modest sales growth, strong global expansion, and robust financial discipline.COLM
Investor presentation - 2026 annual meeting covers director elections, pay, stock plan, and proxy access, with Board opposition to proxy access.COLM
Proxy filing - Q2 sales dropped 8% as U.S. weakness offset gains abroad, but cash and inventory improved.COLM
Q2 2024 - Q1 sales up 1%, outlook withdrawn amid tariff uncertainty; strong cash, share buybacks.COLM
Q1 2025 - Q4 margin gains and international growth contrast with full-year decline; 2025 outlook positive.COLM
Q4 2024